201 Haskins Way
South San Francisco
About Novome Biotechnologies
The future of medicine is cellular. We engineer cell therapies to outsmart chronic diseases. Therapies that are precise, extensible, and act symbiotically with the patient to achieve long-term health. Beyond smart, our therapies are alive.
The microbes in our gut are living pharmacies, producing and consuming many molecules that impact our health. Novome’s unique synthetic biology tools allow us to plug into this ecosystem and deliver precise activities to treat chronic diseases.
Founded on pioneering technology from Stanford University, our proprietary platform enables controllable engraftment of GEMMs in the gut for sustained and truly effective therapies.
1 article with Novome Biotechnologies
Novome Biotechnologies, Inc. today announced the appointment of Bill McLeod as Chief Financial Officer.